Bifogade filer
PDF
Kurs
+0,77%
Kurs
+0,77%
Kalender
| Est. tid* | ||
| 2025-11-27 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | - | Årsstämma |
| 2025-04-25 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-23 | - | Extra Bolagsstämma 2025 |
| 2025-04-11 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2024-11-21 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-02 | - | Extra Bolagsstämma 2024 |
| 2024-05-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-22 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2024-03-21 | - | Årsstämma |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2023-11-23 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-31 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2023-03-30 | - | Årsstämma |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | Årsstämma |
| 2022-03-25 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2022-02-24 | - | Bokslutskommuniké 2021 |
| 2021-11-25 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-01 | - | Extra Bolagsstämma 2021 |
| 2021-05-20 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-26 | - | X-dag ordinarie utdelning CURAS 0.00 DKK |
| 2021-03-25 | - | Årsstämma |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-30 | - | Kvartalsrapport 2020-Q3 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2022-06-24 18:15:51
COPENHAGEN - Curasight A/S ("Curasight" or "the Company" - TICKER: CURAS).
The Company's managerial employee have given Curasight power of attorney on her behalf to publish purchase of Curasight shares as managerial employee conducted in the period 9 - 10 June 2022.
The transaction comprises the following managerial employee;
Name Position Aggregated volume Price, DKK
Hanne Damgaard Jensen Chief Development Officer 16.400 227,218.81
Total 16,400 227,218.81
Hanne Damgaard Jensen total holdings in Curasight A/S after the purchase of the shares is 20,000 shares.
For further information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: uk@curasight.com